Literature DB >> 24522859

Screening low-risk individuals for coronary artery disease.

Chintan S Desai1, Roger S Blumenthal, Philip Greenland.   

Abstract

A large proportion of cardiovascular events occur in individuals classified by traditional risk factors as "low-risk." Efforts to improve early detection of coronary artery disease among low-risk individuals, or to improve risk assessment, might be justified by this large population burden. The most promising tests for improving risk assessment, or early detection, include the coronary artery calcium (CAC) score, the ankle-brachial index (ABI), and the high-sensitivity C-reactive protein (hsCRP). Data regarding the role of additional testing in low-risk populations to improve early detection or to enhance risk assessment are sparse but suggest that CAC and ABI may be helpful for improving risk classification and detecting the higher-risk people from among those at lower risk. However, in the absence of clinical trials in this patient population, such as has recently been proposed, we do not recommend routine use of any additional testing or screening in low-risk individuals at this time.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24522859     DOI: 10.1007/s11883-014-0402-8

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  33 in total

1.  Sick individuals and sick populations.

Authors:  G Rose
Journal:  Int J Epidemiol       Date:  2001-06       Impact factor: 7.196

2.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

3.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

Review 4.  27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management.

Authors:  R M Califf; P W Armstrong; J R Carver; R B D'Agostino; W E Strauss
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

5.  Coronary artery calcium score improves cardiovascular risk prediction in persons without indication for statin therapy.

Authors:  Stefan Möhlenkamp; Nils Lehmann; Philip Greenland; Susanne Moebus; Hagen Kälsch; Axel Schmermund; Nico Dragano; Andreas Stang; Johannes Siegrist; Klaus Mann; Karl-Heinz Jöckel; Raimund Erbel
Journal:  Atherosclerosis       Date:  2010-12-21       Impact factor: 5.162

Review 6.  Inflammation in atherosclerosis: from pathophysiology to practice.

Authors:  Peter Libby; Paul M Ridker; Göran K Hansson
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

Review 7.  2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.

Authors:  Todd J Anderson; Jean Grégoire; Robert A Hegele; Patrick Couture; G B John Mancini; Ruth McPherson; Gordon A Francis; Paul Poirier; David C Lau; Steven Grover; Jacques Genest; André C Carpentier; Robert Dufour; Milan Gupta; Richard Ward; Lawrence A Leiter; Eva Lonn; Dominic S Ng; Glen J Pearson; Gillian M Yates; James A Stone; Ehud Ur
Journal:  Can J Cardiol       Date:  2013-02       Impact factor: 5.223

8.  Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates.

Authors:  Earl S Ford; Simon Capewell
Journal:  J Am Coll Cardiol       Date:  2007-11-13       Impact factor: 24.094

9.  C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.

Authors:  Wolfgang Koenig; Hannelore Löwel; Jens Baumert; Christa Meisinger
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  2 in total

Review 1.  Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus.

Authors:  Sundeep Khosla; Parinya Samakkarnthai; David G Monroe; Joshua N Farr
Journal:  Nat Rev Endocrinol       Date:  2021-09-13       Impact factor: 47.564

2.  Determinants of Bone Material Strength and Cortical Porosity in Patients with Type 2 Diabetes Mellitus.

Authors:  Parinya Samakkarnthai; Jad G Sfeir; Elizabeth J Atkinson; Sara J Achenbach; Paul W Wennberg; Peter J Dyck; Amanda J Tweed; Tammie L Volkman; Shreyasee Amin; Joshua N Farr; Adrian Vella; Matthew T Drake; Sundeep Khosla
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.